These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9537211

  • 1. Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
    Sandler A, Saxman S, Bandealy M, Heilman D, Monaco F, McClean J, Arquette M.
    Am J Clin Oncol; 1998 Apr; 21(2):195-7. PubMed ID: 9537211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck.
    Pai VR, Parikh DM, Mazumdar AT, Rao RS.
    Oncology; 1993 Apr; 50(2):86-91. PubMed ID: 8451041
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G, Ghiani M, Lai P, Maccio A, Dessi D, Succu G, Massa D, Curreli L, Mulas C, Esu S, Proto E, Cadeddu G, Tore G.
    Oncol Rep; 1998 Apr; 5(6):1499-505. PubMed ID: 9769395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: a Gynecologic Oncology Group study.
    Sutton GP, Blessing JA, McGuire WP, Patton T, Look KY.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):805-7. PubMed ID: 8456884
    [Abstract] [Full Text] [Related]

  • 12. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Thurnher D, Kornfehl J, Burian M, Gedlicka C, Selzer E, Quint C, Neuchrist C, Kornek GV.
    Anticancer Drugs; 2001 Mar; 12(3):205-8. PubMed ID: 11290867
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer.
    Buesa JM, Fernández R, Esteban E, Estrada E, Barón FJ, Palacio I, Gracia M, Lacave AJ.
    Ann Oncol; 1991 Feb; 2(2):151-2. PubMed ID: 1905150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck.
    Thödtmann F, Theiss F, Kemmerich M, Heinrich B, Laubenbacher C, Quasthoff S, Kau R, Herzog M, Diergarten K, Hanauske AR.
    Ann Oncol; 1998 Mar; 9(3):335-7. PubMed ID: 9602270
    [Abstract] [Full Text] [Related]

  • 16. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
    Specenier PM, Van Den Brande J, Schrijvers D, Huizing MT, Altintas S, Dyck J, Van Den Weyngaert D, Van Laer C, Vermorken JB.
    Anticancer Res; 2009 Dec; 29(12):5137-42. PubMed ID: 20044628
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G, Fei F, Mangioni C.
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [Abstract] [Full Text] [Related]

  • 18. Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
    Soulières D, Faivre S, Mesía R, Remenár É, Li SH, Karpenko A, Dechaphunkul A, Ochsenreither S, Kiss LA, Lin JC, Nagarkar R, Tamás L, Kim SB, Erfán J, Alyasova A, Kasper S, Barone C, Turri S, Chakravartty A, Chol M, Aimone P, Hirawat S, Licitra L.
    Lancet Oncol; 2017 Mar; 18(3):323-335. PubMed ID: 28131786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
    Cervellino JC, Araujo CE, Pirisi C, Francia A, Cerruti R.
    Oncology; 1991 Mar; 48(2):89-92. PubMed ID: 1900124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.